Phenergan 10 mg and 25 mg FC tablets.
PDF Leaflet Revision Date: 06 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Allergic disorders and anaphylactic reactions.
Dosage (summary)
Adults: Initial 25 mg at night, may increase to 50-100 mg. Daytime: 10 mg three times daily.
Onset of Action / Duration
Onset: 30 mins, Duration: 16-18 hours
Special Populations
- Children under 2 years
- Elderly
- Patients with liver dysfunction
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to risks of neonatal irritability.
Key Drug Interactions
- Caution with QT prolonging drugs
- Avoid alcohol
- Increased effects with sedatives
Contraindications
- Hypersensitivity to promethazine
- Children under 2 years
- Acute asthma attacks
Common side effects
- Sedation
- Dizziness
- Dry mouth
- Nausea
Counselling Points
- Avoid alcohol
- Caution when driving
- Report fever or infections immediately
Serious warnings
- Risk of respiratory depression in children
- QT prolongation
- Neuroleptic malignant syndrome
Important Disclaimer
The Phenergan 10 mg and 25 mg FC tablets. professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
